Skip to main content
. 2017 May 19;8(34):56626–56634. doi: 10.18632/oncotarget.17993

Table 4. Multivariate analysis for pCR predictive parameters.

Variable pCR (n) Non-pCR (n) P value Hazard ratio 95% CI
Menstrual status
 Premenopause 13 30 0.191 2.391 0.647–8.831
 Postmenopause 17 28
Age
 ≤ 35 years 4 9 0.131 4.168 0.655–26.532
 > 35years 26 49
BMI
 ≤ 25 20 34 0.432 1.558 0.516–4.708
 > 25 10 24
Laterality
 Left 14 36 0.121 2.035 0.830–4.993
 Right 16 22
Family history
 Yes 3 3 0.086 0.441 0.173–1.123
 No 27 55
Cycles
 < 4 4 8 0.897 1.102 0.253–4.806
 ≥ 4 26 50
HR status
 Negative 22 22 < 0.001 5.587 2.257–13.889
 Positive 8 36
Ki-67
 High (> 30%) 19 20 0.003 4.130 1.607–10.610
 Low (≤ 30%) 11 38
T stage
 T1–2 24 49 0.780 0.850 0.272–2.659
 T3–4 6 9

pCR: pathologic complete response; BMI: body mass index; HR: hormone receptor; T: tumor; CI: confidence interval.